Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
IO Biotech, Inc. | Chief Executive Officer, Director | Common Stock | 37.4K | $38.7K | $1.04 | Aug 9, 2023 | Direct |
IO Biotech, Inc. | Chief Executive Officer, Director | Common Stock | 26.6K | $27.5K | $1.04 | Aug 9, 2023 | Zocca Consulting ApS |
IO Biotech, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 750K | Mar 15, 2024 | Direct | ||
IO Biotech, Inc. | Chief Executive Officer, Director | Warrants (Right to Buy) | 37K | Aug 9, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IOBT | IO Biotech, Inc. | Mar 15, 2024 | 1 | $0 | 4 | Mar 18, 2024 | Chief Executive Officer, Director |
IOBT | IO Biotech, Inc. | Aug 9, 2023 | 2 | $75K | 4 | Aug 9, 2023 | Chief Executive Officer, Director |
IOBT | IO Biotech, Inc. | Mar 20, 2023 | 1 | $0 | 4 | Mar 22, 2023 | Chief Executive Officer, Director |
IOBT | IO Biotech, Inc. | Nov 9, 2021 | 2 | $0 | 4 | Nov 12, 2021 | Chief Executive Officer, Director |
IOBT | IO Biotech, Inc. | Nov 4, 2021 | 1 | $0 | 4 | Nov 8, 2021 | Chief Executive Officer, Director |
IOBT | IO Biotech, Inc. | Nov 4, 2021 | 0 | $0 | 3 | Nov 4, 2021 | Chief Executive Officer, Director |